Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity
LOS ANGELES, June 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ:ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that Dr. Serhat Gumrukçu, co-founder and inventor of Enochian BioSciences and Director of Seraph Research Institute (SRI), presented data demonstrating daily reduction of Hepatitis B Virus (HBV) until it could no longer be detected by the 8th day. No toxicities to the liver or other tissues were identified. The findings were presented during the prestigious International Liver Conference, and presentations can be found (Link to presentations.) Enochian BioSciences holds the exclusive l
